{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:37:15Z","timestamp":1781620635755,"version":"3.54.5"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Indian Rheumatology Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess chemokine receptor CXCR4 expression in lung parenchyma and on peripheral immune cells in systemic sclerosis-related interstitial lung disease (SSc-ILD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SSc-ILD patients underwent 68Ga- CPCR4 Trifluoroacetate positron emission tomography (PET) scan, SUVmean in different lung regions and architecturally abnormal areas, and receiver operating characteristic (ROC) curves were analysed. CXCR4 expression on peripheral immune cells using flow cytometer was studied and correlated with the different lung regions. In addition, subset analysis of CXCR4 expression by clinical subset (early, progressive, stable), ILD pattern and anti-Scl-70 positivity were done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On PET, SSc-ILD patients showed higher median SUVmean uptake of CXCR4 in the whole lung (0.56; P\u2009&amp;lt;\u20090.0001), different lung regions and architecturally abnormal areas than controls. The highest area under curve (AUC) was observed in dorsobasal regions (AUC-0.91; P\u2009&amp;lt;\u20090.0001) and reticular with architecturally distorted areas (AUC-0.95; P\u2009&amp;lt;\u20090.0001). The progressive subset had higher whole lung median SUVmean (0.73) than early (0.49; P\u2009&amp;lt;\u20090.0001) and stable (0.45; P\u2009&amp;lt;\u20090.0001) subsets, and AUC than early and stable subsets. Usual interstitial pneumonia pattern ILD showed higher CXCR4 uptake compared with non-specific interstitial pneumonia (P\u2009=\u20090.0032). Additionally, a trend for higher uptake was noted in anti-Scl70 positive patients as compared with anti-Scl70 negative ones. SSc-ILD patients had higher CD4+CXCR4+T cells (P\u2009=\u20090.0003) and CD8+CXCR4+T cells (P\u2009=\u20090.0013) and showed moderate to strong association on correlation with the lung parenchymal regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In SSc-ILD, CXCR4 expression is upregulated in both lung parenchyma and peripheral T cells, significantly in progressive and UIP subsets. CXCR4 expression is a potential tool for activity assessment and prognostication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae503","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T07:14:22Z","timestamp":1726902862000},"page":"SI28-SI36","source":"Crossref","is-referenced-by-count":4,"title":["Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-1361","authenticated-orcid":false,"given":"Chirag Rajkumar","family":"Kopp","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-6652","authenticated-orcid":false,"given":"Shefali Khanna","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Subramanian","family":"Krishnaraju","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-0361","authenticated-orcid":false,"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahajal","family":"Dhooria","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-5870","authenticated-orcid":false,"given":"Jagdeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-542X","authenticated-orcid":false,"given":"Ranjana Walker","family":"Minz","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-0694","authenticated-orcid":false,"given":"Varun","family":"Dhir","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-7655","authenticated-orcid":false,"given":"Sanjay","family":"Jain","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research , Chandigarh,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"2025121017320802100_keae503-B1","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.38572","article-title":"Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease","volume":"66","author":"Reese","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2025121017320802100_keae503-B2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","article-title":"Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis","volume":"20","author":"Weigold","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025121017320802100_keae503-B3","doi-asserted-by":"crossref","first-page":"106282","DOI":"10.1016\/j.intimp.2020.106282","article-title":"The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis","volume":"81","author":"Lv","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"2025121017320802100_keae503-B4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J Clin Invest"},{"key":"2025121017320802100_keae503-B5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2025121017320802100_keae503-B6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/rheumatology\/key341","article-title":"CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology"},{"key":"2025121017320802100_keae503-B7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.chest.2020.08.2043","article-title":"Clinical molecular imaging of pulmonary CXCR4 expression to predict outcome of pirfenidone treatment in idiopathic pulmonary fibrosis","volume":"159","author":"Derlin","year":"2021","journal-title":"Chest"},{"key":"2025121017320802100_keae503-B8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12149-018-1290-8","article-title":"CXCR4-directed theranostics in oncology and inflammation","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann Nucl Med"},{"key":"2025121017320802100_keae503-B9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12931-020-01467-0","article-title":"CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis","volume":"21","author":"Jaffar","year":"2020","journal-title":"Respir Res"},{"key":"2025121017320802100_keae503-B10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5114\/aoms.2016.60970","article-title":"Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis","volume":"12","author":"Cipriani","year":"2016","journal-title":"Arch Med Sci"},{"key":"2025121017320802100_keae503-B11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jdermsci.2014.02.008","article-title":"Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease","volume":"74","author":"Le Huu","year":"2014","journal-title":"J Dermatol Sci"},{"key":"2025121017320802100_keae503-B12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1465-9921-14-90","article-title":"Differential regulation of cell functions by CSD peptide subdomains","volume":"14","author":"Reese","year":"2013","journal-title":"Respir Res"},{"key":"2025121017320802100_keae503-B13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/ard.2009.117580","article-title":"Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease","volume":"69","author":"Tourkina","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025121017320802100_keae503-B14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/ard.2008.098277","article-title":"Association between a stromal cell-derived factor 1 (SDF-1\/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis","volume":"68","author":"Manetti","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025121017320802100_keae503-B15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1096\/fba.2018-00015","article-title":"Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4","volume":"1","author":"Su","year":"2019","journal-title":"FASEB bioAdvances"},{"key":"2025121017320802100_keae503-B16","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025121017320802100_keae503-B17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kez483","article-title":"The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients","volume":"59","author":"Peelen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025121017320802100_keae503-B18","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"2025121017320802100_keae503-B19","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"2025121017320802100_keae503-B20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"2025121017320802100_keae503-B21","article-title":"[68Ga]- CPCR4 trifluoroacetate PET\/CT imaging of chemokine receptor CXCR4- expression in systemic sclerosis related interstitial lung disease [abstract]","volume":"74(Suppl 9)","author":"Kopp","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025121017320802100_keae503-B22","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/art.22047","article-title":"Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications","volume":"54","author":"Cipriani","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025121017320802100_keae503-B23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3324\/haematol.12526","article-title":"CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis","volume":"93","author":"Campioni","year":"2008","journal-title":"Haematologica"},{"key":"2025121017320802100_keae503-B24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-021-02460-8","article-title":"18)F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study","volume":"23","author":"Ledoult","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025121017320802100_keae503-B25","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study","volume":"3","author":"Bergmann","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2025121017320802100_keae503-B26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.rti.0000213572.16904.40","article-title":"Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis","volume":"22","author":"Shah","year":"2007","journal-title":"J Thorac Imaging"},{"key":"2025121017320802100_keae503-B27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation","volume":"51","author":"Pijl","year":"2021","journal-title":"Semin Nucl Med"},{"key":"2025121017320802100_keae503-B28","doi-asserted-by":"crossref","first-page":"e220749","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"key":"2025121017320802100_keae503-B29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-022-02292-3","article-title":"Expert consensus on the management of systemic sclerosis-associated interstitial lung disease","volume":"24","author":"Rahaghi","year":"2023","journal-title":"Respir Res"},{"key":"2025121017320802100_keae503-B30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121017320802100_keae503-B31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","article-title":"Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants","volume":"69","author":"Walsh","year":"2014","journal-title":"Thorax"},{"key":"2025121017320802100_keae503-B32","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.2021012953","article-title":"Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenstr\u00f6m macroglobulinemia","volume":"138","author":"Treon","year":"2021","journal-title":"Blood"},{"key":"2025121017320802100_keae503-B33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS-936564\/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies","volume":"19","author":"Kuhne","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2025121017320802100_keae503-B34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2567.2004.02110.x","article-title":"Transforming growth factor-\u03b21 increases CXCR4 expression, stromal-derived factor-1\u03b1-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages","volume":"114","author":"Chen","year":"2005","journal-title":"Immunology"},{"key":"2025121017320802100_keae503-B35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO;2-H","article-title":"TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules","volume":"32","author":"Franitza","year":"2002","journal-title":"Eur J Immunol"},{"key":"2025121017320802100_keae503-B36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42358-021-00182-8","article-title":"Flow cytometry evaluation of CD14\/CD16 monocyte subpopulations in systemic sclerosis patients: a cross sectional-controlled study","volume":"61","author":"Schneider","year":"2021","journal-title":"Adv Rheumatol (London, England)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae503\/59738622\/keae503.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI28\/59738622\/keae503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI28\/59738622\/keae503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:32:21Z","timestamp":1765405941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/SI\/SI28\/7766115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":36,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2024,9,23]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae503","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2024,9,23]]}}}